EcoDrugPlus

Ensembl ID : ENSOMYG00000067869
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSOMYG00000067554
Gene Symbol: -
Cross references: -
505 Possible Orthologues:

Ensembl ID : ENSOMYG00000040752
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSOMYG00000040665
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOMYG00000040706
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSOMYG00000040740
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSOMYG00000067208
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSOMYG00000066769
Gene Symbol: -
Cross references: -
240 Possible Orthologues:

Ensembl ID : ENSOMYG00000040808
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSOMYG00000040815
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSOMYG00000066635
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSOMYG00000047590
Gene Symbol: -
Cross references: -
190 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).